Cargando…

The Efficacy of Faecal Microbiota Transplant and Rectal Bacteriotherapy in Patients with Recurrent Clostridioides difficile Infection: A Retrospective Cohort Study

The most effective treatment for recurrent Clostridioides difficile infection (CDI) is faecal microbiota transplantation (FMT); however, the optimal route of administration is thus far unknown. This retrospective cohort study of 343 patients sought to evaluate the efficacy of treatment with FMT caps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Svensson, Camilla Kara, Cold, Frederik, Ribberholt, Iben, Zangenberg, Mike, Mirsepasi-Lauridsen, Hengameh Chloé, Petersen, Andreas Munk, Helms, Morten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600246/ https://www.ncbi.nlm.nih.gov/pubmed/36291139 http://dx.doi.org/10.3390/cells11203272

Ejemplares similares

Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study
por: Cold, Frederik, et al.
Publicado: (2022)

Effect of α-Hemolysin Producing E. coli in Two Different Mouse Strains in a DSS Model of Inflammatory Bowel Disease
por: Mirsepasi-Lauridsen, Hengameh Chloé, et al.
Publicado: (2020)

Therapy Used to Promote Disease Remission Targeting Gut Dysbiosis, in UC Patients with Active Disease
por: Mirsepasi-Lauridsen, Hengameh Chloè
Publicado: (2022)

Bacteriotherapy
Publicado: (1887)

Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection()
por: Adamu, Blessing O, et al.
Publicado: (2013)

High Abundance of Proteobacteria in Ileo-Anal Pouch Anastomosis and Increased Abundance of Fusobacteria Associated with Increased Pouch Inflammation
por: Petersen, Andreas Munk, et al.
Publicado: (2020)

Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy
por: Cold, Frederik, et al.
Publicado: (2021)

Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea
por: Jeon, Yong Duk, et al.
Publicado: (2019)

The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection
por: D. Goldenberg, Simon, et al.
Publicado: (2021)

Bacteriotherapy in Breast Cancer
por: Yaghoubi, Atieh, et al.
Publicado: (2019)

Secretion of Alpha-Hemolysin by Escherichia coli Disrupts Tight Junctions in Ulcerative Colitis Patients
por: Mirsepasi-Lauridsen, Hengameh Chloé, et al.
Publicado: (2016)

Substantial Intestinal Microbiota Differences Between Patients With Ulcerative Colitis From Ghana and Denmark
por: Mirsepasi-Lauridsen, Hengameh Chloé, et al.
Publicado: (2022)

Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis
por: Baunwall, Simon Mark Dahl, et al.
Publicado: (2020)

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
por: Mirsepasi-Lauridsen, Hengameh Chloé, et al.
Publicado: (2018)

The Regulatory Approach for Faecal Microbiota Transplantation as Treatment for Clostridioides difficile Infection in Italy
por: de Stefano, Maria Chiara, et al.
Publicado: (2022)

Faecal carriage of Clostridioides difficile is low among veterinary healthcare workers in the Netherlands
por: Meijs, Anouk P., et al.
Publicado: (2022)

Bacteriotherapy for inflammatory bowel disease
por: Yoshimatsu, Yusuke, et al.
Publicado: (2021)

Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis
por: Mirsepasi-Lauridsen, Hengameh C., et al.
Publicado: (2016)

Fecal Bacteriotherapy: A Case Report in an Immunosuppressed Patient with Ulcerative Colitis and Recurrent Clostridium difficile Infection
por: Zainah, Hadeel, et al.
Publicado: (2012)

Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection
por: Abdali, Zainab I, et al.
Publicado: (2020)

Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
por: Lawley, Trevor D., et al.
Publicado: (2012)

Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital
por: Barberio, Brigida, et al.
Publicado: (2020)

Faecal microbiota transplantation for Clostridioides difficile infection: Four years’ experience of the Netherlands Donor Feces Bank
por: Terveer, Elisabeth M, et al.
Publicado: (2020)

Faecal microbiota transplantation as a non-standard therapy for the treatment of Clostridioides difficile in an ulcerative colitis patient
por: Pendrasik, Karolina, et al.
Publicado: (2022)

Oxygen Sparing Effect of Bacteriotherapy in COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

The Clinical Efficacy, Safety, and Tolerability of Vancomycin for the Treatment of Recurrent Clostridioides difficile Infection – A Systematic Review
por: Knudsen, Maja Johanne Søndergaard, et al.
Publicado: (2023)

Clostridioides difficile Is Not Difficult to Predict in Hospital Settings
por: Alexander, Kinta, et al.
Publicado: (2021)

Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection
por: Brown, Jillian R.-M., et al.
Publicado: (2018)

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?
por: Batoni, Giovanna, et al.
Publicado: (2022)

Sentinel surveillance and epidemiology of Clostridioides difficile in Denmark, 2016 to 2019
por: Persson, Søren, et al.
Publicado: (2022)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

Complete Genome Sequences of Extraintestinal Pathogenic Escherichia coli Clinical Isolates from Danish Ulcerative Colitis Patients
por: Meski, Simon, et al.
Publicado: (2023)

Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2023)

691. Association between Clostridioides difficile Colonization, Rectal Swab NAAT Positivity, and Environmental Contamination
por: Lee, Mary Morgan, et al.
Publicado: (2023)

Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer
por: Henderson, Emily A., et al.
Publicado: (2023)

Comorbid status and the faecal microbial transplantation failure in treatment of recurrent Clostridioides difficile infection – pilot prospective observational cohort study
por: Kachlíková, M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rmfbqf41femetturtsbeca9eq9